Literature DB >> 15075740

Recent trends in infective endocarditis: influence of case definitions.

Roni K Devlin1, Mary-Margaret Andrews, C Fordham von Reyn.   

Abstract

PURPOSE OF REVIEW: Infective endocarditis continues to pose major challenges in diagnosis and management despite advances in understanding the epidemiology, microbiology, and pathology of the disease. The purpose of this article is to provide a review of diagnosis, microbiology, and treatment of infective endocarditis, particularly as they are influenced by case definitions. RECENT
FINDINGS: Case definitions have a critical effect on the interpretation of trends in infective endocarditis, and recent studies have proposed more specific criteria. Studies have also addressed the appropriate use of echocardiography to assist in the diagnosis and management of infective endocarditis. Staphylococcus aureus has become an increasingly common cause of infective endocarditis, and the microbiology of nosocomial infective endocarditis is changing. Newer techniques are being used to aid in the identification of causal agents in blood culture-negative infective endocarditis. Antimicrobial guidelines for the treatment of infective endocarditis are readily available, including a proposal to avoid premature discharge of patients on outpatient antibiotic therapy. Additional studies have been conducted on combination antibiotic therapy, duration of treatment, dosing of aminoglycosides, alternative agents for gram-positive organisms, aspirin therapy, and surgical interventions.
SUMMARY: Recent trends in diagnosis, microbiology, and treatment of infective endocarditis are described, and case definitions play a critical role in their interpretation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075740     DOI: 10.1097/00001573-200403000-00012

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  8 in total

1.  Role of Echocardiography in Diagnosis and Management of Endocarditis.

Authors:  Ross T Murphy; Mario J Garcia
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

2.  Clinical and microbiological profiles of infective endocarditis in a tertiary hospital in Aseer region, Saudi Arabia.

Authors:  Abdullah S Assiri
Journal:  J Saudi Heart Assoc       Date:  2011-04-21

3.  Evaluation and management of aortic valve and root disease.

Authors:  John B de Graft-Johnson; Thomas G Gleason
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12

4.  An observational study on infective endocarditis: a single center experience.

Authors:  Seyed Mohammad Javad Hosseini; Ramezan Bakhshian; Maryam Moshkani Farahani; Morteza Abdar Esfahani; Amir Bahrami; Ali Sate
Journal:  Res Cardiovasc Med       Date:  2014-11-25

5.  Changing microbiological profile and antimicrobial susceptibility of the isolates obtained from patients with infective endocarditis - The time to relook into the therapeutic guidelines.

Authors:  Rama Gupta; Vandana Kaushal; Abhishek Goyal; Pawan Kumar; Dinesh Gupta; Rohit Tandon; Aashita Mahajan; Sonaal Singla; Gurbhej Singh; Bhupinder Singh; Shibba Takkar Chhabra; Naved Aslam; Gurpreet S Wander; Veenu Gupta; Bishav Mohan
Journal:  Indian Heart J       Date:  2021-11-01

6.  Haematogenous Staphylococcus aureus meningitis. A 10-year nationwide study of 96 consecutive cases.

Authors:  Michael Pedersen; Thomas L Benfield; Peter Skinhoej; Allan G Jensen
Journal:  BMC Infect Dis       Date:  2006-03-16       Impact factor: 3.090

7.  High cell-free DNA predicts fatal outcome among Staphylococcus aureus bacteraemia patients with intensive care unit treatment.

Authors:  Erik Forsblom; Janne Aittoniemi; Eeva Ruotsalainen; Visa Helmijoki; Reetta Huttunen; Juulia Jylhävä; Mikko Hurme; Asko Järvinen
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

8.  Multi-organ embolism caused by oscillating aortic valve vegetation: A case report.

Authors:  Guang Huang; Yu Tang; Rong Xiong; Ainan Xu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.